α1-微球蛋白(a1M)重組蛋白
Recombinant Alpha-1-Microglobulin (a1M)
AMBP; UTI; HCP; EDC1; HI30; IATIL; ITILC; ITI; ITIL; Alpha 1 Microglobulin/Bikunin Precursor; Growth-inhibiting protein 19; Uristatin; Uronic-Acid-Rich Protein; Trypstatin
- 編號RPA217Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量21.9kDa
- 實際分子量25kDa(差異分析請參閱說明書)
- 片段與標簽Val22~Val203 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點6.4
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 912¥ 2280¥ 4560¥ 13680¥ 34200
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure . Gene Sequencing (extract)
SDS-PAGE圖
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APA217Hu61 | α1-微球蛋白(a1M)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA217Hu62 | α1-微球蛋白(a1M)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA217Hu61 | α1-微球蛋白(a1M)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA217Hu62 | α1-微球蛋白(a1M)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA217Hu01 | α1-微球蛋白(a1M)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA217Hu01 | α1-微球蛋白(a1M)多克隆抗體 | WB |
| LAA217Hu71 | α1-微球蛋白(a1M)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA217Hu22 | α1-微球蛋白(a1M)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA217Hu | α1-微球蛋白(a1M)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA217Hu | α1-微球蛋白(a1M)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA217Hu | α1-微球蛋白(a1M)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Diabetes Technology & Therapeutics | Proteomic Identification of Human Urinary Biomarkers in Diabetes Mellitus Type 2 [Liebert: 20100078] |
| Journal of Pharmaceutical and Biomedical Analysis | Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2[PubMed: 21130593] |
| BioMed Research International | Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus[PubMed: PMC3679811] |
| Mainz | Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen[Info:Source] |
| Cellular Physiology and Biochemistry | Activated Α7nachr Improves Postoperative Cognitive Dysfunction and Intestinal Injury Induced by Cardiopulmonary Bypass in Rats: Inhibition of the Proinflammatory?…[Pubmed:29672286] |
| Journal of Clinical Medicine | Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients[Pubmed: 30486327] |